Vous venez de lire:

Movapo® (apomorphine hydrochloride) for Patients with Advanced Parkinson's Disease Now Reimbursed in Most Canadian Provinces

Nouvelles fournies par

Endo International plc

Oct 23, 2019, 07:30 ET